|
1
|
Mollazadegan K, Welin S and Crona J:
Systemic treatment of gastroenteropancreatic neuroendocrine
carcinoma. Curr Treat Options Oncol. 22:682021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A and Evans
DB: One hundred years after ‘carcinoid’: Epidemiology of and
prognostic factors for neuroendocrine tumors in 35,825 cases in the
United States. J Clin Oncol. 26:3063–3072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu IC, Chu YY, Wang YK, Tsai CL, Lin JC,
Kuo CH, Shih HY, Chung CS, Hu ML, Sun WC, et al:
Clinicopathological features and outcome of esophageal
neuroendocrine tumor: A retrospective multicenter survey by the
digestive endoscopy society of Taiwan. J Formos Med Assoc.
120:508–514. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA;
WHO Classification of Tumours Editorial Board, : The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Panzuto F, Andrini E, Lamberti G, Pusceddu
S, Rinzivillo M, Gelsomino F, Raimondi A, Bongiovanni A, Davì MV,
Cives M, et al: Sequencing treatments in patients with advanced
well-differentiated pancreatic neuroendocrine tumor (pNET): Results
from a large multicenter Italian cohort. J Clin Med. 13:20742024.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sultana Q, Kar J, Verma A, Sanghvi S, Kaka
N, Patel N, Sethi Y, Chopra H, Kamal MA and Greig NH: A
comprehensive review on neuroendocrine neoplasms: Presentation,
pathophysiology and management. J Clin Med. 12:51382023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shia J, Tang LH, Weiser MR, Brenner B,
Adsay NV, Stelow EB, Saltz LB, Qin J, Landmann R, Leonard GD, et
al: Is nonsmall cell type high-grade neuroendocrine carcinoma of
the tubular gastrointestinal tract a distinct disease entity? Am J
Surg Pathol. 32:719–731. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ho YH, Hsu CY, Yau Li AF and Liang WY:
Colorectal neuroendocrine carcinoma and mixed
neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and
PD-L1 expression. Hum Pathol. 145:80–85. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tessier-Cloutier B, Kang EY, Alex D,
Stewart CJR, McCluggage WG, Köbel M and Lee CH: Endometrial
neuroendocrine carcinoma and undifferentiated carcinoma are
distinct entities with overlap in neuroendocrine marker expression.
Histopathology. 81:44–54. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gudmundsdottir H, Habermann EB, Vierkant
RA, Starlinger P, Thiels CA, Warner SG, Smoot RL, Truty MJ,
Kendrick ML, Halfdanarson TR, et al: Survival and symptomatic
relief after cytoreductive hepatectomy for neuroendocrine tumor
liver metastases: Long-term follow-up evaluation of more than 500
patients. Ann Surg Oncol. 30:4840–4851. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heetfeld M, Chougnet CN, Olsen IH, Rinke
A, Borbath I, Crespo G, Barriuso J, Pavel M, O'Toole D and Walter
T; Other Knowledge Network Members, : Characteristics and treatment
of patients with G3 gastroenteropancreatic neuroendocrine
neoplasms. Endocr Relat Cancer. 22:657–664. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mischel AM and Rosielle DA: Eastern
cooperative oncology group performance status #434. J Palliat Med.
25:508–510. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Perren A, Couvelard A, Scoazec JY, Costa
F, Borbath I, Delle Fave G, Gorbounova V, Gross D, Grossma A, Jense
RT, et al: Antibes consensus conference participants. Enets
consensus guidelines for the standards of care in neuroendocrine
tumors: Pathology: Diagnosis and prognostic stratification.
Neuroendocrinology. 105:196–200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Emile SH, Horesh N, Garoufalia Z, Gefen R,
Wignakumar A and Wexner SD: Predictors of lymph node metastasis and
survival in radically resected rectal neuroendocrine tumors: A
surveillance, epidemiology, and end results (SEER) database
analysis. Surgery. 176:668–675. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Donofrio CA, Pizzimenti C, Djoukhadar I,
Kearney T, Gnanalingham K and Roncaroli F: Colorectal carcinoma to
pituitary tumour: Tumour to tumour metastasis. Br J Neurosurg.
37:1367–1370. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng K, Duan J, Wang R, Chen H, He H,
Zheng X, Zhao Z, Jing B, Zhang Y, Liu S, et al: Deep learning model
with pathological knowledge for detection of colorectal
neuroendocrine tumor. Cell Rep Med. 5:1017852024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sabella G, Centonze G, Lagano V, Scardino
A, Belli F, Garzone G, Pardo C, Galbiati D, Pusceddu S, Mangogna A,
et al: Unveiling the prognostic role of synaptophysin in
conventional colorectal carcinomas. Neuroendocrinology. 15:632–647.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reina JJ, Serrano R, Codes M, Jiménez E,
Bolaños M, Gonzalez E and Sevilla I: Second primary malignancies in
patients with neuroendocrine tumors. Clin Transl Oncol. 16:921–926.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao W, Jin L, Chen P, Li D, Gao W and
Dong G: Colorectal cancer immunotherapy-Recent progress and future
directions. Cancer Lett. 545:2158162022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Chen H, Zhang J, Wang S, Guan Y,
Gu W, Li J, Zhang X, Li J, Wang X, et al: Molecular features of
gastroenteropancreatic neuroendocrine carcinoma: A comparative
analysis with lung neuroendocrine carcinoma and digestive
adenocarcinomas. Chin J Cancer Res. 36:90–102. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gallo C, Rossi RE, Cavalcoli F, Barbaro F,
Boškoski I, Invernizzi P and Massironi S: Rectal neuroendocrine
tumors: Current advances in management, treatment, and
surveillance. World J Gastroenterol. 28:1123–1138. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chauhan A, Chan K, Halfdanarson TR,
Bellizzi AM, Rindi G, O'Toole D, Ge PS, Jain D, Dasari A, Anaya DA,
et al: Critical updates in neuroendocrine tumors: Version 9
American joint committee on cancer staging system for
gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin.
74:359–367. 2024.PubMed/NCBI
|
|
23
|
Yoshida T, Kamimura K, Hosaka K, Doumori
K, Oka H, Sato A, Fukuhara Y, Watanabe S, Sato T, Yoshikawa A, et
al: Colorectal neuroendocrine carcinoma: A case report and review
of the literature. World J Clin Cases. 7:1865–1875. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rindi G, Mete O, Uccella S, Basturk O, La
Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M
and Asa SL: Overview of the 2022 WHO classification of
neuroendocrine neoplasms. Endocr Pathol. 33:115–154. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Basturk O, Yang Z, Tang LH, Hruban RH,
Adsay V, McCall CM, Krasinskas AM, Jang KT, Frankel WL, Balci S, et
al: The high-grade (WHO G3) pancreatic neuroendocrine tumor
category is morphologically and biologically heterogenous and
includes both well differentiated and poorly differentiated
neoplasms. Am J Surg Pathol. 39:683–690. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Punekar SR, Kaakour D, Masri-Lavine L,
Hajdu C, Newman E and Becker DJ: Characterization of a novel entity
of G3 (high-grade well-differentiated) colorectal neuroendocrine
tumors (NET) in the SEER database. Am J Clin Oncol. 43:846–849.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yachida S, Vakiani E, White CM, Zhong Y,
Saunders T, Morgan R, de Wilde RF, Maitra A, Hicks J, Demarzo AM,
et al: Small cell and large cell neuroendocrine carcinomas of the
pancreas are genetically similar and distinct from
well-differentiated pancreatic neuroendocrine tumors. Am J Surg
Pathol. 36:173–184. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tanaka T, Kaneko M, Nozawa H, Emoto S,
Murono K, Otani K, Sasaki K, Nishikawa T, Kiyomatsu T, Hata K, et
al: Diagnosis, assessment, and therapeutic strategy for colorectal
mixed adenoneuroendocrine carcinoma. Neuroendocrinology.
105:426–434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pommergaard HC, Nielsen K, Sorbye H,
Federspiel B, Tabaksblat EM, Vestermark LW, Janson ET, Hansen CP,
Ladekarl M, Garresori H, et al: Surgery of the primary tumour in
201 patients with high-grade gastroenteropancreatic neuroendocrine
and mixed neuroendocrine-non-neuroendocrine neoplasms. J
Neuroendocrinol. 33:e129672021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Holmager P, Langer SW, Kjaer A, Ringholm
L, Garbyal RS, Pommergaard HC, Hansen CP, Federspiel B, Andreassen
M and Knigge U: Surgery in patients with gastro-entero-pancreatic
neuroendocrine carcinomas, neuroendocrine tumors G3 and high grade
mixed neuroendocrine-non-neuroendocrine neoplasms. Curr Treat
Options Oncol. 23:806–817. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smith JD, Reidy DL, Goodman KA, Shia J and
Nash GM: A retrospective review of 126 high-grade neuroendocrine
carcinomas of the colon and rectum. Ann Surg Oncol. 21:2956–2962.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alese OB, Jiang R, Shaib W, Wu C, Akce M,
Behera M and El-Rayes BF: High-grade gastrointestinal
neuroendocrine carcinoma management and outcomes: A national cancer
database study. Oncologist. 24:911–920. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ordóñez NG: Broad-spectrum
immunohistochemical epithelial markers: A review. Hum Pathol.
44:1195–215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Badzio A, Czapiewski P, Gorczyński A,
Szczepańska-Michalska K, Haybaeck J, Biernat W and Jassem J:
Prognostic value of broad-spectrum keratin clones AE1/AE3 and
CAM5.2 in small cell lung cancer patients undergoing pulmonary
resection. Acta Biochim Pol. 66:111–114. 2019.PubMed/NCBI
|
|
35
|
Vasilevska D, Rudaitis V, Lewkowicz D,
Širvienė D, Mickys U, Semczuk M, Obrzut B and Semczuk A: Expression
patterns of cytokeratins (CK7, CK20, CK19, CK AE1/AE3) in atypical
endometrial hyperplasia coexisting with endometrial cancer. Int J
Mol Sci. 25:90842024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lal P, Saleh MA, Khoudari G, Gad MM,
Mansoor E, Isenberg G and Cooper GS: Epidemiology of large bowel
carcinoid tumors in the USA: A population-based national study. Dig
Dis Sci. 65:269–275. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng X, Wu M, Er L, Deng H, Wang G, Jin L
and Li S: Risk factors for lymph node metastasis and prognosis in
colorectal neuroendocrine tumours. Int J Colorectal Dis.
37:421–428. 2022. View Article : Google Scholar : PubMed/NCBI
|
